1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Flutemetamol (18F) Injection: new trials by email Literature Review of Flutemetamol (18F) Injection trials Research Report on Flutemetamol (18F) Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease Flutemetamol (18F) Injection - Mild Cognitive Impairment, Alzheimer's Disease | Phase 3 | Completed | GE Healthcare | 365 | 2009-12-01 | 2014-09-11 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Communication Disorders (1) · Stroke (1)
GE Healthcare (1)
United States (1)